CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Columbus, Ohio, United States and 71 other locations
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Columbus, Ohio, United States and 32 other locations
Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized ...
Phase 2
Columbus, Ohio, United States and 8 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Columbus, Ohio, United States and 124 other locations
This phase II trial studies how well nivolumab and temozolomide work in treating patients with small-cell lung cancer that has come...
Phase 2
Columbus, Ohio, United States and 1 other location
protein found on the surface of some types of tumor cells, including small-cell lung cancer, and to CD3 which is present ...
Phase 2
Columbus, Ohio, United States
This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung ...
Phase 2
Columbus, Ohio, United States and 4 other locations
PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer ...
Phase 2
Columbus, Ohio, United States of America and 29 other locations
This study will consist of a Phase 1b and Phase 2 portion. The Phase 1b portion will enroll first followed by the Phase 2 portion. Each cycle of trea...
Phase 1, Phase 2
Columbus, Ohio, United States and 2 other locations
of previously-untreated patients with extensive stage small cell lung cancer. Patients will receive initial chemo-immunotherapy fol...
Phase 2
Columbus, Ohio, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal